Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Levoleucovorin × Clear all

NCT06197438 2024-01-09

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms